20 October 2025
Latham & Watkins Represents atai Life Sciences in US$130 Million Public Offering of Common Shares
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Kaj Nielsen | Latham & Watkins LLP | Associate | corporate | Not stated |
| Adam Picker | Latham & Watkins LLP | Associate | corporate | Not stated |
| Elana Cates | Latham & Watkins LLP | Associate | corporate | Not stated |
| Irina Yevmenenko | Latham & Watkins LLP | Counsel | public company representation | Not stated |
| Catriela Cohen | Latham & Watkins LLP | Associate | public company representation | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 130m (US$130 Million)
- What the figure measures
- Issue size
- Client
- atai Life SciencesIssuer
- Counterparties
- Not stated